Japan’s medical startup Anges Incorporated announced Thursday that it will soon begin the country’s first clinical trial on humans for a potential COVID-19 vaccine after receiving the green light from an Osaka University Hospital Committee. | via Kyoko Hashimoto, SMNI Japan Correspondent.
Be the first to comment